AUL
MEDP icon

AlphaGrep UK Ltd’s Medpace MEDP Stock Holding History

AlphaGrep UK Ltd’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$654K Sell
1,362
-413
-23% -$211K 0.19% 125
2025
Q4 		$997K Buy
+1,775
New +$1.01M 0.33% 36

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AlphaGrep UK Ltd's MEDP Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its Medpace (MEDP) stake by 23% in Q1 2026, selling an estimated $211K and leaving 1,362 shares worth $654K. The position accounts for 0.19% of the portfolio, ranked #125.

AlphaGrep UK Ltd first reported a position in MEDP in Q4 2025 and has held it in 2 quarters since. The position peaked at $997K in Q4 2025. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • AlphaGrep UK Ltd held 1,362 shares of Medpace worth $654K as of Q1 2026.
  • AlphaGrep UK Ltd sold 413 Medpace shares in Q1 2026, an estimated $211K.
  • Medpace made up 0.19% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #125 holding.
  • AlphaGrep UK Ltd first reported a position in Medpace in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's Medpace position peaked at $997K in Q4 2025.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.